Tatsuki Tsuruga, Hajime Fujimoto, Taro Yasuma, Corina N D'Alessandro-Gabazza, Masaaki Toda, Toshiyuki Ito, Atsushi Tomaru, Haruko Saiki, Tomohito Okano, Manal A B Alhawsawi, Atsuro Takeshita, Kota Nishihama, Reoto Takei, Yasuhiro Kondoh, Isaac Cann, Esteban C Gabazza, Tetsu Kobayashi
BACKGROUND: Coagulopathy is a major cause of morbidity and mortality in COVID-19 patients. Hypercoagulability in COVID-19 results in deep vein thrombosis, thromboembolic complications, and diffuse intravascular coagulation. Microbiome dysbiosis influences the clinical course of COVID-19. However, the role of dysbiosis in COVID-19-associated coagulopathy is not fully understood. OBJECTIVES: The present study tested the hypothesis that the microbiota-derived proapoptotic corisin is involved in the coagulation system activation during SARS-CoV-2 infection...
March 5, 2024: Journal of Thrombosis and Haemostasis: JTH